1National Institute of Health Research Biomedical Research Unit in Respiratory Disease, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
2Department of Medical Physics, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
J Aerosol Med Pulm Drug Deliv. 2019 Aug;32(4):175-188. doi: 10.1089/jamp.2017.1441. Epub 2019 Mar 8.
Mucociliary clearance (MCC) rate from the lung has been shown to be reduced in chronic obstructive pulmonary disease (COPD). This study compared the use of change in penetration index (PI) with conventional whole lung clearance in assessing MCC in mild-to-moderate disease. Measurement of lung MCC using planar gamma camera imaging was performed in three groups: (1) healthy nonsmoking controls ( = 9), (2) smoking controls who were current smokers with normal lung function ( = 10), and (3) current smokers with mild-to-moderate COPD and bronchitis ( = 15). The mean (±standard deviation) forced expiratory volume at 1 second (FEV) for the three groups was 109 (±18), 94 (±5), and 78 (±12), respectively. Following inhalation of a technetium-99m labeled aerosol, planar imaging was performed over 4 hours and then at 24 hours. Total lung clearance and tracheobronchial clearance (TBC; normalized to 24-hour clearance) were calculated. A novel parameter, the normalized change in PI (NOCHIP), was also evaluated. PI is the ratio of counts between outer and inner lung zones normalized to lung volume. More aerosol was deposited in central airways in COPD compared to nonsmoking controls, using 24-hour clearance measurements ( < 0.001). Smoking controls had intermediate values. The optimal endpoint for MCC assessment was chosen to be 3 hours, when intersubject variability was minimal, while preserving a measure of early clearance. There was no statistical difference between the three groups in mean total lung clearance, or TBC, at 3 hours. NOCHIP at 3 hours was reduced significantly, compared to nonsmoking controls, in both smoking controls ( = 0.007) and COPD ( < 0.0001). It also correlated with FEV ( = 0.003). A higher proportion of smoking control subjects had NOCHIP values in the nonsmoking control range than in the COPD group. NOCHIP was a more sensitive measure of MCC than whole lung clearance and TBC in mild-to-moderate COPD.
肺黏液清除率(MCC)已被证明在慢性阻塞性肺疾病(COPD)中降低。本研究比较了穿透指数(PI)变化与常规全肺清除率在评估轻度至中度疾病中的 MCC 中的应用。使用平面伽马相机成像测量三组肺 MCC:(1)健康不吸烟对照者(=9),(2)当前吸烟但肺功能正常的吸烟对照者(=10),和(3)有轻度至中度 COPD 和支气管炎的当前吸烟者(=15)。三组的平均(±标准差)1 秒用力呼气量(FEV)分别为 109(±18)、94(±5)和 78(±12)。吸入锝-99m 标记的气溶胶后,在 4 小时和 24 小时进行平面成像。计算全肺清除率和气管支气管清除率(TBC;归一化为 24 小时清除率)。还评估了一个新参数,归一化 PI 变化(NOCHIP)。PI 是内外肺区计数与肺容积之比的比值。与不吸烟对照者相比,COPD 中更多的气溶胶沉积在中央气道中,使用 24 小时清除率测量(<0.001)。吸烟对照者处于中间值。选择 MCC 评估的最佳终点为 3 小时,此时个体间变异性最小,同时保留早期清除的指标。三组在 3 小时时的平均全肺清除率或 TBC 无统计学差异。与不吸烟对照者相比,吸烟对照者(=0.007)和 COPD 者(<0.0001)的 3 小时 NOCHIP 明显降低,并且与 FEV(=0.003)相关。与 COPD 组相比,更多的吸烟对照者的 NOCHIP 值处于不吸烟对照者范围内。NOCHIP 是一种比全肺清除率和 TBC 更敏感的轻度至中度 COPD 中 MCC 的测量方法。